The novel therapy of this peptide represents a exciting advance in the handling of the condition. Unlike existing medications, tirzepatide affects dual pathways – GLP-1 and glucose-dependent insulinotropic https://tirzepatidepeptide182033.bloginwi.com/75871907/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment